Prostate Cancer | Tumor

Inaccurate Information on Cancer Diagnosis and Treatment Common on Social Media Sites

July 30th 2021, 9:00pm


Articles containing misinformation on social media sites like Facebook and Twitter were more likely to be shared and liked than those with accurate information.

Cancer Remission: Time to Breathe Again

July 26th 2021, 4:00pm


A survivor of prostate cancer celebrates the news that his cancer has not spread and describes how remission has made him feel.

Obese Patients Tend to Have Better Prostate Cancer Outcomes

July 20th 2021, 1:00pm


Despite this “obesity paradox,” doctors do not recommend gaining weight with hopes of improving cancer outcomes.

‘Friends’ Actor James Michael Tyler Announces Prostate Cancer Diagnosis

June 21st 2021, 2:48pm


The disease, which advanced to his spine and bones, prevented him from appearing onstage for the “Friends” reunion.

Better Prostate Cancer Screening for Younger African American Men May Improve Outcomes

June 16th 2021, 1:00pm


Reaching a younger age group of African American men for prostate cancer detection may improve their survival outcomes, says an expert from the University of California San Diego.

Novel Therapy Appears Safe in Certain Patients with Prostate Cancer

June 7th 2021, 6:30pm


The treatment was also associated with antitumor activity in patients with metastatic castration-resistant prostate cancer.

Certain Patients with Prostate Cancer Continue to Tolerate Extended Nubeqa Treatment

June 6th 2021, 1:00pm


Patients with nonmetastatic castration-resistant prostate cancer continued to tolerate long-term treatment with Nubeqa, allowing them to maintain their quality of life and remain on therapy.

Men of African Ancestry Less Likely to Receive Genomic Profiling Early During Prostate Cancer Treatment

June 5th 2021, 4:00pm


The data, according to one of the study’s authors, are critical in understanding the disparities in prostate cancer.

Investigational Therapy Significantly Improves Survival in Patients with Prostate Cancer

June 4th 2021, 5:00pm


The addition of an investigational therapy to standard-of-care treatment was associated with a median overall survival of 15.3 months in patients with progressive PSMA-positive metastatic castration-resistant prostate cancer.

FDA Approves First PET Imaging Agent to Identify Prostate Cancer Metastasis or Recurrence

May 27th 2021, 2:43pm


The PET imaging agent targets prostate-specific membrane antigen levels, which can improve the detection of suspected disease spread or recurrence compared with standard approaches.